[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"substance-related-disorder\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:substance-related-disorder":59},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100642004","the-enhance-project-toolkit-100642004",false,"NCT07649278","The ENHANCE Project Toolkit","Mobile Health Strategies to Support Longitudinal Engagement in Comprehensive, Community-based Prevention Services for People Who Use Drugs (Aim 3)","Inclusion Criteria (Pilot Participant):\n\n* Be at least 18 years old\n* Be able to read and write in English\n* Report drug use in the past 30 days, defined as\n\n  * Any use of illicit stimulants, opioids, OR\n  * Use of prescription opioids by a route other than \"by mouth\u002Fswallowed\"\n* Additionally report recent drug use of at least twice in the past 7 days\n* Have NOT used any of the following harm reduction services in the past 6 months:\n\n  * In-person community-based prevention services for people who use drugs\n  * Overdose crisis hotlines\n  * Online mail-order prevention supply delivery\n  * Apps for supporting addiction treatment or recovery\n\nInclusion Criteria (Peer Mentor Participant):\n\n* Be at least 18 years old\n* Be able to read and write in English\n* Have served as a member of the existing Community Leadership Team.\n\nExclusion Criteria:\n\n* Are under the age of 18\n* Have impaired decision making capacity at the time of screening\n* Do not have the ability to participate in screening and enrollment activities in any one of the following ways:\n\n  * Traveling to their nearest participating Vivent Health health center\n  * Coordinating a visit with the Vivent Health harm reduction mobile unit\n  * Accessing and completing the online screening survey on a personal wifi\u002Finternet enabled device","ALL","18 Years",{"count":19,"type":20},40,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study will examine the feasibility, appropriateness, and acceptability of a bundle of smartphone-based tools for lowering overdose risk. 40 participants will be enrolled and can expect to be on study for up to 9 months.",[26,27,28],"Substance Related Disorder","Drug Overdose","eHealth",[30,31],"Substance Use Disorder","Opioid Use Disorder","NOT_YET_RECRUITING","2026-06-10",{"date":35,"type":36},"2026-06-16","ACTUAL",{"date":38,"type":20},"2026-06",{"date":40,"type":20},"2027-06",{"name":42,"class":43},"University of Wisconsin, Madison","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":21,"phases":55,"briefSummary":56,"conditions":57,"keywords":60,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":44},"100582070","deficit-hyperactivity-disorder--substance-use-disorder-comorbidity-in-integrated-treatment-100582070","NCT06858527","Deficit Hyperactivity Disorder \u002F Substance Use Disorder Comorbidity in Integrated Treatment","Adults With Attention Deficit Hyperactivity Disorder \u002F Substance Use Disorder Comorbidity in Integrated Treatment: Effectiveness and Feasibility","ATTenTIFF","Inclusion Criteria:\n\n* Age 18 or older ;\n* Suffer from at least one moderate to severe SUD regarding the DSM-5 (tobacco excluded) ;\n* Being currently treated for a SUD by a physician of a psychologist ;\n* Being diagnosed with an ADHD according to the DIVA 2.0 of DIVA-5 ;\n* Being affiliated to a health insurance ;\n* Understanding and being able to express himselves in French\n* Signed consent\n\nExclusion Criteria:\n\n* Age under 18;\n* Pregnant or breastfeeding women;\n* Not having sign the consent form;\n* Major difficulties in understanding and\u002For expressing themselves in french;\n* Severe cognitive impairment;\n* Acute medical condition making assessment impossible and\u002For contraindicating participation in group intervention;\n* Substance use disorder in a protected environment, currentlu or in the last 15 days, or expected during the study;\n* No substance use disorder other than tobacco use disorder;\n* Persons under guardianship;\n* Participant deprived of liberty or under penal care orders;\n* Participation in another group psychotherapeutic intervention throughout the duration of the intervention",{"count":54,"type":20},132,[23],"Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders (SUDs) is a highly common comorbid condition associated with serious medical and psychosocial consequences. However, and despite the international consensus recommending integrated treatment for this comorbidity, few studies tested the efficacy of specific psychotherapeutic treatment for this comorbidity.\n\nThe aim of this study is to test the efficacy of a specific group Cognitive and Behavioral Therapy (CBT) for the treatment of adults with this comorbidity.\n\nThis is a longitudinal, randomized controlled intervention study utilizing a crossover design between the intervention and treatment-as-usual (TAU) waitlist condition, aimed at testing the effectiveness of an integrated psychotherapeutic group treatment for adults with comorbid Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders (SUDs).",[58,59],"Attention Deficit Hyperactivity Disorder (ADHD)","Substance-related Disorder",[61,62,63,64,65],"Attention Deficit Hyperactivity Disorder","Substance-Related Disorders","Cognitive Behavioral Therapy","Dual Diagnosis","Randomized Controlled Trial","RECRUITING","2025-06-23",{"date":69,"type":36},"2025-06-26",{"date":71,"type":36},"2025-04-01",{"date":73,"type":20},"2029-07",{"name":75,"class":43},"Assistance Publique - Hôpitaux de Paris"]